Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 3/2022

24.10.2021 | Original Paper

The role of three dimensional transesophageal echocardiography novel-score in the success of redo percutaneous balloon mitral valvuloplasty

verfasst von: Kadriye Memic Sancar, Gamze Babur Guler, Halil Ibrahim Tanboga, Ali Riza Demir, Ahmet Anil Sahin, Omer Tasbulak, Seda Tukenmez Karakurt, Tugba Aktemur, Yalcın Avci, Umit Bulut, Meltem Tekin, Ekrem Guler, Ali Kemal Kalkan, Mehmet Erturk

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Mitral valve commissure evaluation is known to be important in the success of percutaneous balloon mitral valvuloplasty (PBMV) and Wilkins score (WS) is used in clinical practice. In our study, we aimed to determine whether WS in redo PBMV is sufficient in the success of procedure and additionally we have evaluated a novel scoring system including three dimensional (3D) transesophageal echocardiography (TEE) of the mitral valve structure before redo PBMV in terms of success of the procedure. Fifty patients who underwent redo PBMV were included in the study. The patients were divided into two groups according to the success of the Redo PBMV procedure which was defined as post-procedural MVA ≥ 1.5 cm2 and post-procedural mitral regurgitation less than moderate by echocardiographic evaluation after PBMV. A novel score based on 3D TEE findings was created by analyzing the images recorded before Redo PBMV and by evaluating the mitral commissure and calcification. The role of traditional WS and novel score in the success of the procedure were investigated. In the study group, 36 patients (72%) had successful redo PBMV procedure. WS was 8 (IQR 7–9) and novel 3D TEE score was found 4 (IQR 3–4) in the whole study group. While no statistically significant relationship was found between WS and procedural success (p = 0.187), a statistically significant relationship was found between novel 3D TEE score and procedural success (p = 0.042). Specifically, the procedural successes rate was > 90% when novel 3D TEE score was < 4. The novel 3D TEE score might be an informative scoring system in the selection of suitable patients for successful redo PBMV, especially in patients who are considered for surgery due to the high WS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N (1984) Clinical applications of intravenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 87:394–402CrossRef Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N (1984) Clinical applications of intravenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 87:394–402CrossRef
2.
Zurück zum Zitat Lock JE, Khalilullah M, Shrivastava S, Bahl V, Keane JF (1985) Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med 313:1515–1518CrossRef Lock JE, Khalilullah M, Shrivastava S, Bahl V, Keane JF (1985) Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med 313:1515–1518CrossRef
3.
Zurück zum Zitat Iung B, Cormier B, Ducimetiere P et al (1996) Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol 27:407–414CrossRef Iung B, Cormier B, Ducimetiere P et al (1996) Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol 27:407–414CrossRef
4.
Zurück zum Zitat Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e72–e227. https://doi.org/10.1161/CIR.0000000000000923 (Erratum in: Circulation)CrossRefPubMed Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e72–e227. https://​doi.​org/​10.​1161/​CIR.​0000000000000923​ (Erratum in: Circulation)CrossRefPubMed
5.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, DeBonis M, Hamm C, Holm PJ et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef Baumgartner H, Falk V, Bax JJ, DeBonis M, Hamm C, Holm PJ et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef
6.
Zurück zum Zitat Wilkins GT, Weyman AE, Abascal VM et al (1988) Percutaneous dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60:299–308CrossRef Wilkins GT, Weyman AE, Abascal VM et al (1988) Percutaneous dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60:299–308CrossRef
7.
Zurück zum Zitat Abascal VM, Wilkins GT, Choong CY et al (1988) Echocardiographic evaluation of mitral valve structure and function in patients followed for at least six months after percutaneous mitral balloon valvuloplasty. J Am Coll Cardiol 12:606–615CrossRef Abascal VM, Wilkins GT, Choong CY et al (1988) Echocardiographic evaluation of mitral valve structure and function in patients followed for at least six months after percutaneous mitral balloon valvuloplasty. J Am Coll Cardiol 12:606–615CrossRef
8.
Zurück zum Zitat Fatkin D, Roy P, Morgan J, Feneley MP (1993) Percutaneous balloon mitral valvotomy with the Inoue single balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 21:390–397CrossRef Fatkin D, Roy P, Morgan J, Feneley MP (1993) Percutaneous balloon mitral valvotomy with the Inoue single balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 21:390–397CrossRef
10.
Zurück zum Zitat Pathan AZ, Mahdi NA, Leon MN, Lopez-Cuellar J, Simosa H, Block PC, Harrell L, Palacios IF (1999) Is redo percutaneous mitralballoon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis? J Am Coll Cardiol 34:49–54CrossRef Pathan AZ, Mahdi NA, Leon MN, Lopez-Cuellar J, Simosa H, Block PC, Harrell L, Palacios IF (1999) Is redo percutaneous mitralballoon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis? J Am Coll Cardiol 34:49–54CrossRef
11.
Zurück zum Zitat Iung B, Garbarz E, Michaud P, Fondard O, Helou S, Kamblock J, Berdah P, Michel PL, Lionet P, Cormier B, Papouin G, Vahanian A (2000) Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J 21:1683–1689CrossRef Iung B, Garbarz E, Michaud P, Fondard O, Helou S, Kamblock J, Berdah P, Michel PL, Lionet P, Cormier B, Papouin G, Vahanian A (2000) Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J 21:1683–1689CrossRef
12.
Zurück zum Zitat Turgeman Y, Atar S, Suleiman K, Feldman A, Bloch L, Jabaren M, Rosenfeld T (2005) Feasibility, safety, and morphologic predictors of outcome of repeat percutaneous balloon mitral commissurotomy. Am J Cardiol 95:989–991CrossRef Turgeman Y, Atar S, Suleiman K, Feldman A, Bloch L, Jabaren M, Rosenfeld T (2005) Feasibility, safety, and morphologic predictors of outcome of repeat percutaneous balloon mitral commissurotomy. Am J Cardiol 95:989–991CrossRef
13.
Zurück zum Zitat Kim JB, Ha JW, Kim JS, Shim WH, Kang SM, Ko YG, Choi D, Jang Y, Chung N, Cho SY, Kim SS (2007) Comparison of long-term outcome after mitral valve replacement or repeated balloon mitral valvotomy in patients with restenosis after previous balloon valvotomy. Am J Cardiol 99:1571–1574CrossRef Kim JB, Ha JW, Kim JS, Shim WH, Kang SM, Ko YG, Choi D, Jang Y, Chung N, Cho SY, Kim SS (2007) Comparison of long-term outcome after mitral valve replacement or repeated balloon mitral valvotomy in patients with restenosis after previous balloon valvotomy. Am J Cardiol 99:1571–1574CrossRef
14.
Zurück zum Zitat Bassand J, Schiele F, Bernard Y et al (1991) Double balloon and Inoue techniques in percutaneous mitral valvotomy: comparativeresults in a series of 232 cases. J Am Coll Cardiol 18:982–989CrossRef Bassand J, Schiele F, Bernard Y et al (1991) Double balloon and Inoue techniques in percutaneous mitral valvotomy: comparativeresults in a series of 232 cases. J Am Coll Cardiol 18:982–989CrossRef
15.
Zurück zum Zitat Cannan CR, Nishimura RA, Reeder GS et al (1997) Echocardiographic assessment of commissural calcium: a simplepredictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol 29:175–180CrossRef Cannan CR, Nishimura RA, Reeder GS et al (1997) Echocardiographic assessment of commissural calcium: a simplepredictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol 29:175–180CrossRef
16.
Zurück zum Zitat Post JR, Feldman T, Isner J, Herrmann HC et al (1995) Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. J Am Coll Cardiol 25:1129–1136CrossRef Post JR, Feldman T, Isner J, Herrmann HC et al (1995) Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. J Am Coll Cardiol 25:1129–1136CrossRef
19.
Zurück zum Zitat Block PC, Palacios IF, Jacobs MC, Fallon IT (1987) Mechanisms at percutaneous mitral balloonvalvotomy. Am J Cardiol 59:178–179CrossRef Block PC, Palacios IF, Jacobs MC, Fallon IT (1987) Mechanisms at percutaneous mitral balloonvalvotomy. Am J Cardiol 59:178–179CrossRef
20.
Zurück zum Zitat Reifart N, Nowak B, Baykut D, Satter P, Bussmann WD, Kaltenbach M (1990) Experimental balloon valvuloplasty of fibrotic and calcific mitral valves. Circulation 81:1005–1011CrossRef Reifart N, Nowak B, Baykut D, Satter P, Bussmann WD, Kaltenbach M (1990) Experimental balloon valvuloplasty of fibrotic and calcific mitral valves. Circulation 81:1005–1011CrossRef
21.
Zurück zum Zitat Reid CL, McKay CR, Chandraratna PA, Kawanishi DT, Rahimtoola SH (1987) Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 76(3):628–636. https://doi.org/10.1161/01.cir.76.3.628CrossRefPubMed Reid CL, McKay CR, Chandraratna PA, Kawanishi DT, Rahimtoola SH (1987) Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 76(3):628–636. https://​doi.​org/​10.​1161/​01.​cir.​76.​3.​628CrossRefPubMed
23.
Zurück zum Zitat Messika-Zeitoun D, Brochet E, Holmin C, Rosenbaum D, Cormier B, Serfaty JM, Iung B, Vahanian A (2007) Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. Eur Heart J 28(1):72–79. https://doi.org/10.1093/eurheartj/ehl206CrossRefPubMed Messika-Zeitoun D, Brochet E, Holmin C, Rosenbaum D, Cormier B, Serfaty JM, Iung B, Vahanian A (2007) Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. Eur Heart J 28(1):72–79. https://​doi.​org/​10.​1093/​eurheartj/​ehl206CrossRefPubMed
24.
Zurück zum Zitat Langerveld J, Valocik G, Plokker HW et al (2003) Additional value of three dimensional transesophageal echocardiography for patients with mitral valve stenosis under going balloon valvuloplasty. J Am Soc Echocardiogr 16:841–849CrossRef Langerveld J, Valocik G, Plokker HW et al (2003) Additional value of three dimensional transesophageal echocardiography for patients with mitral valve stenosis under going balloon valvuloplasty. J Am Soc Echocardiogr 16:841–849CrossRef
25.
Zurück zum Zitat Zamorano J, Perez de Isla L, Sugeng L et al (2004) Non-invasive assessment of mitral valve areaduring percutaneous balloon mitral valvuloplasty: role of real-time 3D echocardiography. Eur Heart J 25:2086–2091CrossRef Zamorano J, Perez de Isla L, Sugeng L et al (2004) Non-invasive assessment of mitral valve areaduring percutaneous balloon mitral valvuloplasty: role of real-time 3D echocardiography. Eur Heart J 25:2086–2091CrossRef
27.
Zurück zum Zitat Sutaria N, Northridge DB, Shaw TR (2000) Significance of commissural calcification on outcome of mitral balloonvalvotomy. Heart 84:398–402CrossRef Sutaria N, Northridge DB, Shaw TR (2000) Significance of commissural calcification on outcome of mitral balloonvalvotomy. Heart 84:398–402CrossRef
Metadaten
Titel
The role of three dimensional transesophageal echocardiography novel-score in the success of redo percutaneous balloon mitral valvuloplasty
verfasst von
Kadriye Memic Sancar
Gamze Babur Guler
Halil Ibrahim Tanboga
Ali Riza Demir
Ahmet Anil Sahin
Omer Tasbulak
Seda Tukenmez Karakurt
Tugba Aktemur
Yalcın Avci
Umit Bulut
Meltem Tekin
Ekrem Guler
Ali Kemal Kalkan
Mehmet Erturk
Publikationsdatum
24.10.2021
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 3/2022
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-021-02452-4

Weitere Artikel der Ausgabe 3/2022

The International Journal of Cardiovascular Imaging 3/2022 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.